81% rise in Victoza sales drives Novo Nordisk earnings

Article Date: 27/04/2012 10:33
81% rise in Victoza sales drives Novo Nordisk earnings

Vacancy Search

Quick job search

Advanced Search

Latest News

Vietnam pharma market "to grow 20% to 2017"

Vietnam pharma market "to grow 20% to 2017"

Novartis 'transforms' itself with multi-billion-dollar GSK, Lilly deals

Novartis 'transforms' itself with multi-billion-dollar GSK, Lilly deals

How oncology, vaccines and OTC will look after pharma’s game of musical chairs

The unusual switcheroo pulled by GlaxoSmithKline and Novartis today will cause enormous changes to the landscape in the key areas of oncology and vaccines, as well as in the consumer health...

Pfizer has done it before, but an AstraZeneca bid would be a big surprise

Was Pfizer’s approach to AstraZeneca pushed to the press to ratchet up the pressure on the underperforming company’s board, or was it a red herring to throw off the scent of another huge...

Pfizer's $101-billion move on AstraZeneca

Pfizer's $101-billion move on AstraZeneca

Free samples lead doctors to prescribe costlier drugs: study

Free samples lead doctors to prescribe costlier drugs: study

Weekly Market Movers (to 18 Apr 2014)

EvaluatePharma’s EventAnalyzer delivers a weekly global round up of key events driving company valuations.

FDA approves Merck & Co's Ragwitek

FDA approves Merck & Co's Ragwitek

Orphan status for BI leukaemia drug in USA and EU

Orphan status for BI leukaemia drug in USA and EU

OxSyBio raises £1m to develop 3D bio printer

OxSyBio raises £1m to develop 3D bio printer
more news